In the study on the ability of microbial metabolites to regulate the tumor microenvironment by non-targeted metabonomics, the researchers found that TMAO inhibits tumor growth by activating CD8+ T cell-mediated antitumor immunity. This evidence concerns the gene CD8A and neoplasm.